Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
LOS ANGELES, Aug. 8, 2013 (GLOBE NEWSWIRE) -- Response Genetics, Inc. (Nasdaq:RGDX), a company focused on the development and sale of molecular diagnostic tests that help determine a patient’s response to cancer therapy, today announced its consolidated financial results and business progress for the second quarter ended June 30, 2013.
Help employers find you! Check out all the jobs and post your resume.
